CD274 and ovarian cancer: Although we have previously reported the differential expression pattern and prognostic value of PD-L1 on human myeloid cells isolated from ovarian cancer patients [16], removal of monocytes from TICS is necessary to demonstrate the effects of immune checkpoint blocking antibody and to reduce donor-to-donor variability.